News

PiKe Pharma is the coordinator of the ongoing FP7 project “FLUINHIBIT” worth 1.5 million Euro.

Pike Pharma has been awarded a prize for one of the best business ideas in the “Venture 2008” competition of McKinsey and the ETH Zürich.